Bone mineral density in patients with cystic fibrosis: dual energy X-ray absorptiometry.

被引:4
作者
Duveau, E
Beringue, F
Pellier, I
Audran, M
Ginies, JL [1 ]
机构
[1] CHU Angers, Dept Pediat, F-49033 Angers, France
[2] CHU Angers, Serv Rhumatol, F-49033 Angers, France
来源
ARCHIVES DE PEDIATRIE | 1999年 / 6卷 / 07期
关键词
cystic fibrosis; bone density; osteoporosis; absorptiometry; photon; child;
D O I
10.1016/S0929-693X(99)80353-4
中图分类号
R72 [儿科学];
学科分类号
100202 ;
摘要
Background. - The aim of this study was to assess the bone mineral density of cystic fibrosis patients. Patients and methods. - We have retrospectively studied 45 patients with cystic fibrosis, 22 females and 23 males, aged between six and 27 years (mean 13 +/- 5.5 years). Nutritional status, Shwachman score, pulmonary function, serum calcium and 25-hydroxyvitamin D levels and lumbar bone mineral de,density by dual energy X-ray obsorptiometry were assessed. Results. - The average height of the patients was 97 +/- 44e (range: 86-106) and body mass index 93 +/- 10% (range 77-114) of the normal values of age. The average Shwachman, score was 80 +/- 11/100 (range: 47-96). The forced expiratory volume in Is teas 80 +/- 29% (21-128) and the viral capacity 85 +/- 21% (range: 40-122) of the predicted values. The serum levels of calcium and 25-hydroxyvitamin D were lower than normal values in six cases and orle case respectively. Thirty-eight patients had a mean lumbar spine bone mineral Z-score,which was -1.35 +/- 1.2 DS and 84.7 +/- 13.5% of the normal values. It was correlated,vith the height, the body mass index, the Shwachman score, the FEV I and the viral capacity, Conclusion, - Decreased bone density is frequent a,among cystic fibrosis subjects. It shows a lack of control of the illness. It remains unknown,l with usual investigation; the dual X-ray absorptiometry,should, each time it is possible, take parr of investigations in those patients. (C) 1999 Elsevier, Paris.
引用
收藏
页码:720 / 724
页数:5
相关论文
共 22 条
[1]   Biphosphonates [J].
Allgrove, J .
ARCHIVES OF DISEASE IN CHILDHOOD, 1997, 76 (01) :73-75
[2]   OSTEOPENIA IN ADULTS WITH CYSTIC-FIBROSIS [J].
BACHRACH, LK ;
LOUTIT, CW ;
MOSS, RB ;
MARCUS, R .
AMERICAN JOURNAL OF MEDICINE, 1994, 96 (01) :27-34
[3]  
Bhudhikanok GS, 1996, PEDIATRICS, V97, P103
[4]   Bone acquisition and loss in children and adults with cystic fibrosis: A longitudinal study [J].
Bhudhikanok, GS ;
Wang, MC ;
Marcus, R ;
Harkins, A ;
Moss, RB ;
Bachrach, LK .
JOURNAL OF PEDIATRICS, 1998, 133 (01) :18-27
[5]  
DENNING CR, 1968, PEDIATRICS, V41, P7
[6]   THE CHANGING EPIDEMIOLOGY OF CYSTIC-FIBROSIS [J].
FITZSIMMONS, SC .
JOURNAL OF PEDIATRICS, 1993, 122 (01) :1-9
[7]   Bisphosphonates: Preclinical aspects and use in osteoporosis [J].
Fleisch, HA .
ANNALS OF MEDICINE, 1997, 29 (01) :55-62
[8]   OSTEOPOROSIS IN CYSTIC-FIBROSIS [J].
GIBBENS, DT ;
GILSANZ, V ;
BOECHAT, MI ;
DUFER, D ;
CARLSON, ME ;
WANG, CI .
JOURNAL OF PEDIATRICS, 1988, 113 (02) :295-300
[9]   Cyclic administration of pamidronate in children with severe osteogenesis imperfecta [J].
Glorieux, FH ;
Bishop, NJ ;
Plotkin, H ;
Chabot, G ;
Lanoue, G ;
Travers, R .
NEW ENGLAND JOURNAL OF MEDICINE, 1998, 339 (14) :947-952
[10]   BONE-MINERAL DENSITY AND BODY-COMPOSITION IN ADULT PATIENTS WITH CYSTIC-FIBROSIS [J].
GREY, AB ;
AMES, RW ;
MATTHEWS, RD ;
REID, IR .
THORAX, 1993, 48 (06) :589-593